CHERYL WALKER to Insulin Receptor Substrate Proteins
This is a "connection" page, showing publications CHERYL WALKER has written about Insulin Receptor Substrate Proteins.
Connection Strength
0.578
-
Loss of inhibitory insulin receptor substrate-1 phosphorylation: An early event in endometrial hyperplasia and progression to carcinoma. Cell Cycle. 2010 Jul 15; 9(14):2698-9.
Score: 0.327
-
Placental DNA methylation levels at CYP2E1 and IRS2 are associated with child outcome in a prospective autism study. Hum Mol Genet. 2019 08 15; 28(16):2659-2674.
Score: 0.154
-
Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma. Cancer Prev Res (Phila). 2010 Mar; 3(3):290-300.
Score: 0.080
-
Developmental reprogramming of IGF signaling and susceptibility to endometrial hyperplasia in the rat. Lab Invest. 2008 Jun; 88(6):615-26.
Score: 0.018